WallStreetZenWallStreetZen

NASDAQ: KTTA
Pasithea Therapeutics Corp Stock Ownership - Who owns Pasithea Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pasithea Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tiago MarquesChief Executive Officer2025-05-12960$0.83
$792.00Sell

1 of 1

KTTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KTTA insiders and whales buy or sell their stock.

KTTA Shareholders

What type of owners hold Pasithea Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pd Joint Holdings LLC Series 2016a35.05%2,608,696$1.80MInsider
Eric Shahinian24.03%1,788,415$1.23MInsider
Lawrence Steinman17.23%1,282,174$883.42kInsider
Israel Maxx Abramowitz14.13%1,051,575$724.54kInsider
Avi Geller13.90%1,034,702$712.91kInsider
Dean Lazer12.13%902,600$621.89kInsider
Eric Lazer12.13%902,600$621.89kInsider
Yassine Bendiabdallah4.03%300,000$206.70kInsider
David Delaney3.06%227,521$156.76kInsider
Advisorshares Investments LLC0.72%53,547$36.89kInstitution

1 of 3

KTTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KTTA0.77%99.23%Net SellingNet Selling
ATNF0.23%99.77%
GLTO2.09%97.91%Net SellingNet Selling
MTNB0.95%99.05%
CMND11.72%0.00%
View Top Biotech Stocks

Pasithea Therapeutics Stock Ownership FAQ

Who owns Pasithea Therapeutics?

Pasithea Therapeutics (NASDAQ: KTTA) is owned by 1.06% institutional shareholders, 136.92% Pasithea Therapeutics insiders, and 0.00% retail investors. Pd Joint Holdings LLC Series 2016a is the largest individual Pasithea Therapeutics shareholder, owning 2.61M shares representing 35.05% of the company. Pd Joint Holdings LLC Series 2016a's Pasithea Therapeutics shares are currently valued at $1.80M.

If you're new to stock investing, here's how to buy Pasithea Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.